Latest California Healthline Stories
EpiPen Controversy Fuels Concerns Over Generic Drug Approval Backlog
Four years after a huge push to speed generics to market, the FDA has more than 4,000 generics waiting for approval.
Government-Protected ‘Monopolies’ Drive Drug Prices Higher, Study Says
Researchers at Harvard University examined thousands of studies to determine why drug prices have climbed and what might be done about it.
Sen. Hernandez Pulls Bill On Drug Price Transparency
The legislation would have required drug companies to notify the state and insurers about expensive new treatments or price hikes.
Drug Price Transparency Bill Clears Key Hurdle in California Legislature
The end of August is the deadline for lawmakers to make a final decision on the measure, which would require pharmaceutical companies to provide advance notice of large price increases and introduction of expensive new drugs.
Can Drug Price Transparency Keep Costs Down?
California is among a number of states considering new laws to control the rising cost of prescription medications.
Medical Marijuana Linked To Modest Budget Benefits For Medicare Part D, Study Finds
A Health Affairs study determines that Part D spending went down slightly on prescription drugs for which medical marijuana is viewed as a possible alternative.
Sounds Like A Good Idea? Regulating Drug Prices
Presidential candidates from both parties have proposals they say would help lower the cost of prescription drugs. But most experts say that efforts to regulate prices might not end up saving much money.
California Drug Price Transparency Bill Clears Key Committee
The controversial measure was amended to address drugmakers’ concerns; some lawmakers were confused by the legislation.
Medi-Cal gastará cerca de mil millones en drogas para la hepatitis C el próximo año
En total, el gasto en hepatitis C está aumentando porque más personas están tomando los costosos medicamentos nuevos. Pero el costo por paciente está bajando.
California Drug Price Measure Fiercely Opposed By Pharmaceutical Industry
Proposed legislation would require drugmakers to disclose and justify price hikes. The industry has taken to Facebook and Twitter, warning that the proposal could lead to medication shortages in some regions of the state.